Device Trial Radar · NCT06011148
Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese Population
Last checked: Nov 19, 2026Latest source record: Mar 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Dec 2024
Primary completion
Dec 2025
Study completion Dec 2025
Sponsor
- Lead sponsor
- Corcym S.r.lNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 25, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety information on the Perceval S sutureless prosthetic heart valve after the implantation for aortic valve disease. The study is designed as a post-market, observational, non-interventional retrospective and prospective registry.
Conditions
- Aortic Valve Disease
Interventions
Perceval S sutureless heart valveDevice
Aortic Valve Replacement with Perceval S sutureless heart valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- MortalityTime frame: up to 1 year
- Structural valve deteriorationTime frame: up to 1 year
- Cerebral thromboembolismTime frame: up to 1 year
5 more outcomes with a free account
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.